Table 4 Hazard ratios for death from all-cause and cardiovascular causes according to physical indicators*.

From: Physical Health Indicators Improve Prediction of Cardiovascular and All-cause Mortality among Middle-Aged and Older People: a National Population-based Study

Indicators

Entire cohort

Participants without CVD at baseline

Cardiovascular death

All-cause death

Cardiovascular death

All-cause death

95% CI

P-value

95% CI

P-value

95% CI

P-value

95% CI

P-value

Framingham risk score

ā€ƒ1-SD increase

2.7 (1.7–4.4)

<0.001

1.9 (1.5–2.3)

<0.001

1.9 (1.1–3.4)

0.024

1.6 (1.3–2.2)

<0.001

ā€ƒ<10%

Reference

Ā 

Reference

Ā Ā Ā Ā Ā 

ā€ƒ10%–20%

2.5 (0.6–10.4)

0.213

1.7 (0.9–3.3)

0.130

1.7 (0.3–8.3)

0.529

2.0 (0.9–4.2)

0.086

ā€ƒā‰„0%

6.5 (1.8–23.1)

0.004

3.4 (1.9–6.1)

<0.001

3.0 (0.7–12.7)

0.128

3.1 (1.5–6.3)

0.002

High-sensitivity CRP†

ā€ƒ1-SD increase

1.7 (1.2–2.3)

0.001

1.5 (1.3–1.8)

<0.001

1.7 (1.2–2.5)

0.007

1.4 (1.2–1.7)

0.001

ā€ƒ>3.0 mg/l—§

3.4 (1.4–8.3)

0.008

2.6 (1.6–4.3)

<0.001

3.0 (0.9–10.2)

0.077

2.1 (1.1–3.8)

0.02

Dominant handgrip strength†

ā€ƒ1-SD increase

0.4 (0.2–0.8)

0.004

0.4 (0.3–0.6)

<0.001

0.4 (0.2–0.8)

0.007

0.4 (0.3–0.6)

<0.001

ā€ƒ<14.3 kg women, <22.4 kg men—

4.3 (1.6–11.3)

0.004

3.8 (2.2–6.5)

<0.001

7.3 (2.0–26.8)

0.003

5.2 (2.7–10.0)

<0.001

ā€ƒ<16.0 kg women <28.0 kg men§

4.2 (1.5–11.5)

0.006

3.1 (1.8–5.4)

<0.0001

8.5 (2.2–32.2)

0.002

4.1 (2.1–7.9)

<0.0001

Relative handgrip strength*

ā€ƒ1-SD increase

0.5 (0.3–0.8)

0.006

0.5 (0.3–0.6)

<0.001

0.4 (0.2–0.8)

0.006

0.4 (0.3–0.6)

<0.001

ā€ƒ<0.79 women, <1.32 men—

1.1 (0.1–8.6)

0.914

2.3 (1.0–5.2)

0.050

0.0 (0.0–NR)

0.995

2.4(0.8–7.1)

0.121

ā€ƒ<1.40 women, <2.34 men§

3.4 (1.2–9.5)

0.017

3.9 (2.2–7.0)

<0.0001

6.3 (1.5–26.1)

0.011

4.6(2.3–9.2)

<0.0001

Walking speed†

ā€ƒ1-SD increase

0.7 (0.4–1.2)

0.179

0.8 (0.6–1.1)

0.110

0.7 (0.3–1.5)

0.313

0.8(0.6–1.2)

0.293

ā€ƒ<0.8 m/s—,§

1.0 (0.3–2.7)

0.925

1.2 (0.7–2.1)

0.526

0.8 (0.2–3.3)

0.734

1.3(0.6–2.5)

0.526

Peak expiratory flow†

ā€ƒ1-SD increase

0.4 (0.2–0.8)

0.011

0.5 (0.4–0.7)

<0.001

0.4 (0.2–0.9)

0.037

0.5(0.4–0.8)

0.003

ā€ƒ<250.0 l/min—,§

3.2 (1.2–8.5)

0.023

2.7 (1.6–4.7)

0.0003

3.3 (0.8–13.5)

0.104

2.6(1.3–5.1)

0.005

  1. CVD, cardiovascular disease; CI, confidence interval; SD, standard deviation; CRP, C-reactive protein; NR, not reached.
  2. *Results were calculated by Cox regression analysis. Data were adjusted for: age at baseline (continuous); sex (binary); systolic blood pressure (continuous); use or nonuse of antihypertensive medication (binary); total cholesterol (continuous); high-density lipoprotein cholesterol (continuous); use or nonuse of lipid lowering medication (binary); presence or absence of diabetes (binary); smoking status (binary).
  3. †Data were adjusted for variables listed in footnote* plus body mass index (continuous).
  4. —Cut-off values according to previous literature.
  5. §Cut-off values according to this study.